Tirzepatide's dual-action approach Tirzepatide (found in Mounjaro and Zepbound) works differently by activating not one, but two hormone receptors: GLP-1 receptors (the same ones that semaglutide targets) GIP (glucose-dependent insulinotropic polypeptide) receptors This dual-action approach creates complementary effects on hunger, metabolism, and blood sugar regulation and yielding more impactful results than GLP-1 alone
[DOI] [PubMed] [Google Scholar] Besterman HS, Cook GC, Sarson DL, Christofides ND, Bryant MG, Gregor M, Bloom SR
All participants were thoroughly briefed on the study and provided written informed consent
This can easily lead to cardiac arrhythmias (Dridi et al
It is also used in the management of neuropathic pain and diabetic neuropathy, providing support for neurological disorders involving nerve degeneration